Health Information Management

Tip of the week: Consider reporting a V58 code with ESA therapy

APCs Insider, August 22, 2008

Billers at the University of Texas’ MD Anderson Cancer Center encountered difficulties with local guidance when they reported chemotherapy-induced anemia as a diagnosis with no encounter for chemotherapy. When reporting erythropoietin stimulating agent (ESA) therapy, the facility’s local coverage determination (LCD) required it to report anemia as the diagnosis with a code for the chemotherapy encounter. Billers ran afoul of this LCD when the patient received an oral administration of chemotherapy and became anemic secondary to the regimen, said Angela Simmons, CPA, director of clinical revenue and reimbursement at MD Anderson.

Post a Comment

Name:

 

E-mail:

 

Please enter your comment below:

   

Please enter the text below:

   
   
    Briefings on APCs
  • Briefings on APCs

    Worried about the complexities of the new rules under OPPS and APCs? Briefings on APCs helps you understand the new rules...

  • HIM Briefings

    Guiding Health Information Management professionals through the continuously changing field of medical records and toward a...

  • Briefings on Coding Compliance Strategies

    Submitting improper Medicare documentation can lead to denial of fees, payback, fines, and increased diligence from payers...

  • Briefings on HIPAA

    How can you minimize the impact of HIPAA? Subscribe to Briefings on HIPAA, your health information management resource for...

  • APCs Insider

    This HTML-based e-mail newsletter provides weekly tips and advice on the new ambulatory payment classifications regulations...

Most Popular